









Markets
/
Stocks
/
nasdaq-rxrx
/

Recursion Pharmaceuticals Inc

RXRX

View Detailed Chart

5.030USD

-0.370-6.85%

Close 06/27, 16:00（ET）Quotes delayed by 15 min

2.04BMarket Cap

LossP/E TTM



Recursion Pharmaceuticals Inc

5.030

-0.370-6.85%

Company

Intraday

30m

Today

-6.85%

5 Days

0.00%

1 Month

+14.58%

6 Months

-31.94%

Year to Date

-25.59%

1 Year

-33.60%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

HOLD

Current Rating

6.667

Target Price

23.46%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

557

Total

Median

Average

Company name

Ratings

Analysts

Recursion Pharmaceuticals Inc

RXRX

Exact Sciences Corp

EXAS

CRISPR Therapeutics AG

CRSP

Regeneron Pharmaceuticals Inc

REGN

Intellia Therapeutics Inc

NTLA

Moderna Inc

MRNA

...

112

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(7)

Neutral(3)

Buy(3)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.042

Buy

RSI(14)

50.952

Neutral

STOCH(KDJ)(9,3,3)

56.281

Neutral

ATR(14)

0.422

Low Volatility

CCI(14)

-5.703

Neutral

Williams %R

77.037

Sell

TRIX(12,20)

0.451

Sell

StochRSI(14)

24.263

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

5.128

Sell

MA10

5.054

Sell

MA20

4.992

Buy

MA50

4.916

Buy

MA100

5.869

Sell

MA200

6.341

Sell

News

More news coming soon, stay tuned...

Company

Recursion Pharmaceuticals, Inc. is a clinical stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology include REC-617, REC-1245, REC-3565 and REC-4539. Its clinical programs in rare diseases include REC-994, REC-4881, REC-2282, and REC-3964. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors.

Ticker SymbolRXRX

CompanyRecursion Pharmaceuticals Inc

CEODr. Christopher Gibson, Ph.D.

Websitehttps://www.recursion.com/